DNMT3A and myeloproliferative disorder: Mutations in TET2 and DNMT3A are also frequently associated with myeloid malignancies, including acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN), and myelodysplastic/myeloproliferative neoplasms (MDS/MPN).